The language of aesthetic medicine has shifted considerably in recent years. Where conversations once centred almost exclusively on volume replacement and the correction of visible lines, there is now a growing and well-founded interest in a different category of treatment — one that works not by adding a foreign substance to replace lost tissue, but by encouraging the body to regenerate its own.
Biostimulators sit at the centre of this shift. They represent a fundamentally different philosophy of skin treatment: one oriented toward long-term tissue quality rather than immediate correction. Understanding what they are, how they work, and how they differ from traditional volume replacement agents is one of the most useful pieces of knowledge a person can have when navigating their options in skin health.
The Problem That Both Approaches Are Trying to Solve
To understand the distinction between biostimulators and volume replacement agents, it helps to first understand the underlying biology they are each responding to.
As the face ages, it loses three things simultaneously: structural volume, skin quality, and tissue support. The fat compartments of the face deflate and descend. The collagen and elastin matrix of the dermis thins and becomes disorganised. The scaffolding of the extracellular matrix (the gel-like environment that supports healthy cell function) becomes depleted of the molecules that keep it hydrated and biologically active. The result is a face that looks not simply older, but structurally different: flatter, less supported, and with skin that has lost its inherent quality and resilience.
Both biostimulators and volume replacement agents are, in different ways, responding to this same set of changes. They simply do so through very different mechanisms, and with very different timelines and outcomes.
Volume Replacement: Restoring What Has Been Lost
Traditional volume replacement agents, most commonly hyaluronic acid-based dermal fillers, work by physically occupying space within the tissue. When injected into an area that has lost volume, they restore projection, lift, and contour by adding material where tissue has been lost.
This is a well-established, evidence-supported approach with a strong safety profile when performed by a skilled and experienced practitioner. The effects are immediate and visible. The product integrates with the surrounding tissue and, over time, is gradually broken down by the body’s natural enzymatic processes. Results are typically maintained for anywhere between six months and two years, depending on the product used, the area treated, and the individual’s metabolism.
The important distinction is that volume replacement is largely a mechanical intervention. It fills a space. It does not, in itself, prompt the body to produce new structural tissue or improve the intrinsic quality of the skin. For some clients and some concerns, that immediate, precise correction is exactly what is needed. For others, particularly those interested in long-term skin health and gradual, natural-looking improvement, a different approach may be more appropriate.
Biostimulators: Working With the Body, Not Instead of It
Biostimulators take a fundamentally different approach. Rather than replacing lost volume with an external substance, they work by stimulating the body’s own biological processes — prompting fibroblasts, the collagen-producing cells of the dermis, to increase their activity and generate new structural tissue.
The mechanism varies depending on the specific agent, but the underlying principle is consistent: the biostimulator acts as a signal, triggering a controlled biological response within the tissue. Over the weeks and months following treatment, the body responds by producing new collagen, elastin, and other structural proteins. The improvement is not the product itself, it is the tissue the body generates in response to it.
This has several meaningful implications. First, the results develop gradually, which, for many clients, translates to a more natural-looking outcome. There is no sudden change in appearance; instead, the skin improves progressively, in a way that tends to look entirely consistent with the person’s own biology. Second, because the improvement is driven by genuine tissue regeneration, the results tend to have a quality and longevity that differs from volume replacement. Third, the treatment addresses not just volume loss but the underlying quality of the tissue itself, improving skin thickness, firmness, and surface quality alongside any structural changes.
Different Biostimulators, Different Mechanisms
It is worth noting that biostimulators are not a single uniform category. Several distinct substances are classified as biostimulators, and while they share the same fundamental goal, they differ in their composition, mechanism of action, and the type of tissue response they generate.
Poly-L-lactic acid (PLLA) is one of the most established biostimulators, with a long clinical history. It works by creating a controlled inflammatory response that stimulates fibroblast activity and progressive collagen deposition over several months. Results build gradually across a course of treatments.
Calcium hydroxyapatite (CaHA) is a mineral compound that occurs naturally in the body — it is the same mineral that gives bones and teeth their structural strength. When used as a biostimulator, the microspheres provide an immediate scaffolding effect while simultaneously stimulating collagen and elastin production in the surrounding tissue. Over time, the microspheres are metabolised and what remains is the body’s own newly generated collagen.
Polynucleotides (PDRN/PN) represent a newer and rapidly evolving category. Derived from highly purified DNA fragments, polynucleotides work by stimulating cellular repair and regeneration, supporting fibroblast function, and improving the hydration and quality of the extracellular matrix. Their mechanism is distinct from collagen-stimulating agents — they work more at the level of cellular health and tissue environment than direct collagen induction.
Each of these has different clinical applications, different timelines, and different ideal candidates. Understanding which approach (or which combination) is most appropriate for a given individual is a clinical decision that requires a thorough assessment.
Choosing the Right Approach
The question of whether volume replacement, biostimulation, or a combination of both is most appropriate is not one with a universal answer. It depends on what is driving the changes an individual is experiencing, what their goals are, what their timeline looks like, and what their skin health is like at baseline.
Younger clients with early signs of collagen decline and an interest in prevention may find that biostimulation alone, combined with a strong homecare routine, is the most appropriate strategy. Clients with more significant volume loss may benefit from a combination approach, using a volume replacement agent to restore structural support while incorporating biostimulation to improve the underlying tissue quality. Others may prioritise the gradual, regenerative quality of biostimulators as their primary approach, accepting a longer timeline in exchange for results that feel entirely their own.
What is clear is that the most effective outcomes come from treating the face as a whole — understanding the multiple layers and drivers of change, and selecting an approach that addresses them thoughtfully. This is precisely the conversation that a skilled aesthetic consultation is designed to facilitate.
The shift toward regenerative thinking in aesthetic medicine is not a trend. It reflects a deeper and increasingly well-evidenced understanding of what the skin needs to remain healthy, resilient, and vital over the long term. Biostimulators are a meaningful part of that conversation, and for many people, they represent a more aligned approach to how they want to age.
